For laboratory research use only. Not for human or animal consumption.
BioIntegrityResearch

Cellular Repair & Recovery

VIP

Vasoactive intestinal peptide

Vasoactive Intestinal Peptide

Research context

VIP is a 28-residue amidated neuropeptide belonging to the secretin/glucagon superfamily. Research examines binding at the VPAC1 and VPAC2 receptor subtypes, cAMP accumulation, and cytokine profile measurement in immune cell preparations.

Common assays: VPAC1/VPAC2 binding · cAMP accumulation · Cytokine profiling

Specification

DesignationVasoactive intestinal peptide
Full nameVasoactive Intestinal Peptide
SequenceHis-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH₂
CAS number37221-79-7
Molecular formulaC147H238N44O42S
Molecular weight3325.80 g/mol
Formats10 mL Vial
SolubilitySterile water, bacteriostatic water
StorageLyophilised: −20 °C, desiccated. Reconstituted: 2–8 °C, use promptly.

Published literature

Selected peer-reviewed references describing research involving this compound. Listed for reference only; inclusion is not a claim about any outcome.

  1. Delgado M, Ganea D.Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functionsAmino Acids · 2013 Find on PubMed ↗

Common questions

What receptors does VIP act at?

VPAC1 and VPAC2, both class B G protein-coupled receptors. It also has affinity for the PAC1 receptor, so selectivity panels typically include all three.

Why is prompt use recommended after reconstitution?

VIP contains methionine, which is oxidation-prone, and the C-terminal amide is required for activity. Both argue for short solution storage and aliquoting at first reconstitution.

Same pathway

Related compounds